Business Context and Reporting Period
This Form 6-K filing by Evogene Ltd. (a foreign private issuer) was submitted on June 17, 2025. The document serves as a notice regarding the company's Annual General Meeting of Shareholders, scheduled for August 11, 2025, at its principal executive offices in Rehovot, Israel.
Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report is a corporate governance notice and does not contain financial statements or performance data.
Material Changes
No material financial changes versus a prior comparable period are disclosed in this filing. The document focuses solely on the logistics and agenda of the upcoming shareholder meeting.
Guidance, Outlook, and Corporate Governance
- Meeting Details: The Annual General Meeting is set for 3:00 p.m. Israel time on Monday, August 11, 2025.
- Record Date: Shareholders of record as of the close of business on Monday, June 23, 2025, are entitled to vote.
- Exhibits: The filing incorporates by reference the Notice of Meeting (Exhibit 99.1), Proxy Statement (Exhibit 99.2), and Proxy Card (Exhibit 99.3). These documents detail the agenda, voting procedures, and board of directors information.
- Registration Statements: The contents are incorporated into active registration statements on Form F-3 and Form S-8.
Key Facts for Investor Verification
- Verify the specific proposals to be voted on by reviewing the attached Proxy Statement (Exhibit 99.2), as the summary text does not list the agenda items.
- Confirm share ownership status by the record date of June 23, 2025, to ensure voting eligibility.
- Note that this filing contains no financial performance data; investors should refer to the most recent Form 20-F or quarterly reports for financial metrics.